You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: February 10, 2025

Drug Price Trends for ALLERGY-CONGESTION RLF


✉ Email this page to a colleague

« Back to Dashboard


Drug Price Trends for ALLERGY-CONGESTION RLF

Average Pharmacy Cost for ALLERGY-CONGESTION RLF

These are average pharmacy acquisition costs (net of discounts) from a US national survey
Drug Name NDC Price/Unit ($) Unit Date
ALLERGY-CONGESTION RLF 12H TAB 00113-2007-60 0.77870 EACH 2025-01-22
ALLERGY-CONGESTION RLF 12H TAB 00113-2007-60 0.78027 EACH 2024-12-18
ALLERGY-CONGESTION RLF 12H TAB 00113-2007-60 0.76038 EACH 2024-11-20
ALLERGY-CONGESTION RLF 12H TAB 00113-2007-60 0.81391 EACH 2024-10-23
ALLERGY-CONGESTION RLF 12H TAB 00113-2007-60 0.77933 EACH 2024-09-18
ALLERGY-CONGESTION RLF 12H TAB 00113-2007-60 0.79664 EACH 2024-08-21
>Drug Name >NDC >Price/Unit ($) >Unit >Date

Market Analysis and Price Projections for Allergy-Congestion Relief Drugs

Market Overview

The market for allergy and congestion relief drugs is part of the broader allergic rhinitis treatment market, which is experiencing significant growth driven by several key factors.

Global Market Size and Growth

The global allergic rhinitis treatment market is estimated to be valued at USD 16.10 billion in 2024 and is expected to reach USD 22.43 billion by 2031, exhibiting a compound annual growth rate (CAGR) of 4.8% during this period[1].

Regional Dynamics

North America dominates the global allergic rhinitis treatment market, holding approximately 37.4% of the market share in 2024. This dominance is attributed to the region's developed healthcare infrastructure and the strong presence of leading pharmaceutical manufacturers in the U.S.[1].

Demand Drivers

Increasing Environmental Pollution

Rapid urbanization and industrialization have led to increased pollution levels, resulting in higher instances of allergies and other respiratory diseases. This environmental factor is a significant driver for the demand of allergy and congestion relief drugs[1].

Growing Health Consciousness

There is a rising awareness among consumers regarding the availability and benefits of various treatment options for allergic rhinitis. This increased health consciousness is driving the demand for both prescription and over-the-counter (OTC) medication options[1].

Busy Lifestyles and Convenience

Modern consumers, with their busy lifestyles, often prefer OTC medicines as they are more convenient and do not require a doctor's visit. This preference is particularly evident in the rising sales of OTC bronchodilators and antihistamines[3].

Market Segments

Over-the-Counter (OTC) Medicines

The OTC cough, cold, and allergy medicine market is expected to grow at a CAGR of 5.5% from 2022 to 2032, reaching a valuation of USD 66.54 billion by 2032. This growth is fueled by the rising demand for OTC antihistamine drugs and the increasing adoption of OTC medicines over prescription drugs[3].

Prescription Medicines

While OTC medicines are gaining traction, prescription medicines remain a significant segment. The seasonal allergic rhinitis market, for example, is driven by advancements in targeted therapies and biologics, and is expected to reach USD 14.1 billion by 2034, growing at a CAGR of 2.76% during 2024-2034[4].

Price Projections

Current Pricing

The cost for Allergy & Congestion Relief (loratadine/pseudoephedrine) oral tablets can range from $12.46 to $14.52 for a supply of 10 tablets, depending on the pharmacy and the use of discount cards[2].

Generic Versions

Generic versions of these medications are available and often priced lower, such as loratadine/pseudoephedrine, which can cost from $12.46 for 10 tablets[2].

Future Pricing Trends

Market Competition

The presence of generic versions and the expiry of patents for blockbuster drugs may lead to competitive pricing strategies among pharmaceutical companies. This competition is expected to keep prices relatively stable or even reduce them over time[1].

Economic Factors

Improving economic conditions and increased product awareness are expected to influence pricing. In regions like the U.S., higher willingness to spend on medication is anticipated to support market growth, although it may not necessarily lead to higher prices due to the competitive nature of the market[3].

Regional Pricing Variations

North America

In North America, particularly in the U.S., the prices for allergy and congestion relief drugs are influenced by the strong healthcare infrastructure and the presence of well-established pharmaceutical companies. Prices here tend to be relatively stable due to market competition and consumer awareness[1].

Asia Pacific

In the Asia Pacific region, the pricing of branded drugs is relatively high compared to generics. However, industry players are focusing on affordable product offerings to tap into the rising demand from a large patient pool. Partnerships with local pharmaceutical companies are also helping to reduce costs by strengthening supply chain and distribution networks[1].

Key Takeaways

  • The global allergic rhinitis treatment market is expected to grow significantly, driven by environmental pollution, growing health consciousness, and the convenience of OTC medicines.
  • The OTC cough, cold, and allergy medicine market is projected to grow at a CAGR of 5.5% from 2022 to 2032.
  • Prices for allergy and congestion relief drugs are expected to remain competitive due to the presence of generic versions and market competition.
  • Regional variations in pricing are influenced by local healthcare infrastructure, consumer awareness, and economic conditions.

FAQs

1. What is the projected growth rate of the global allergic rhinitis treatment market? The global allergic rhinitis treatment market is expected to grow at a CAGR of 4.8% from 2024 to 2031[1].

2. Which region dominates the global allergic rhinitis treatment market? North America dominates the global allergic rhinitis treatment market, holding approximately 37.4% of the market share in 2024[1].

3. What are the key drivers of the demand for allergy and congestion relief drugs? Key drivers include increasing environmental pollution, growing health consciousness, and the convenience of OTC medicines[1][3].

4. How is the OTC cough, cold, and allergy medicine market expected to grow? The OTC cough, cold, and allergy medicine market is expected to grow at a CAGR of 5.5% from 2022 to 2032, reaching a valuation of USD 66.54 billion by 2032[3].

5. What factors influence the pricing of allergy and congestion relief drugs? Pricing is influenced by market competition, the presence of generic versions, economic conditions, and regional healthcare infrastructure[1][2][3].

Sources

  1. Coherent Market Insights - Allergic Rhinitis Treatment Market - Share, Size and Industry Analysis
  2. Drugs.com - Allergy & Congestion Relief Prices, Coupons, Copay Cards & Patient Assistance
  3. Fact.MR - OTC Cough, Cold & Allergy Medicine Market 2032
  4. BioSpace - Seasonal Allergic Rhinitis Market to Reach US$ 14.1 Billion by 2034
  5. BioSpace - Pollen Allergy Market Estimated to Reach a CAGR of 2.79% during 2024-2034

More… ↓

⤷  Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.